Ahmed M Abu El-Asrar Selected Research

cobaltous chloride (cobalt(II)chloride)

5/2021	Apocynin ameliorates NADPH oxidase 4 (NOX4) induced oxidative damage in the hypoxic human retinal Müller cells and diabetic rat retina.
1/2021	CD146/Soluble CD146 Pathway Is a Novel Biomarker of Angiogenesis and Inflammation in Proliferative Diabetic Retinopathy.
1/2021	Tissue Inhibitor of Metalloproteinase-3 Ameliorates Diabetes-Induced Retinal Inflammation.
5/2020	Interleukin-11 Overexpression and M2 Macrophage Density are Associated with Angiogenic Activity in Proliferative Diabetic Retinopathy.
12/2016	Upregulation of Thrombin/Matrix Metalloproteinase-1/Protease-Activated Receptor-1 Chain in Proliferative Diabetic Retinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ahmed M Abu El-Asrar Research Topics

Disease

50	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 08/2006
29	Epiretinal Membrane (Epiretinal Membranes) 01/2022 - 09/2006
28	Inflammation (Inflammations) 04/2022 - 04/2007
23	Uveitis 09/2022 - 09/2004
11	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 09/2022 - 10/2010
9	Hypoxia (Hypoxemia) 01/2022 - 06/2007
8	Retinal Detachment (Retinal Detachments) 12/2021 - 06/2005
6	Macular Edema 03/2021 - 06/2005
6	Proliferative Vitreoretinopathy 02/2018 - 09/2006
5	Fibrosis (Cirrhosis) 12/2014 - 03/2012
4	Tuberculosis (Tuberculoses) 06/2021 - 12/2008
4	Necrosis 01/2020 - 01/2010
4	Cataract (Cataracts) 01/2019 - 04/2010
3	Sarcoidosis (Schaumann Disease) 04/2020 - 01/2016
3	Glaucoma 02/2015 - 10/2009
2	Neoplasms (Cancer) 10/2021 - 01/2014
2	Ischemia 10/2020 - 06/2010
2	Vitreous Hemorrhage 10/2020 - 08/2006
2	Wounds and Injuries (Trauma) 05/2018 - 06/2014
2	Infections 01/2018 - 10/2010
2	Hemorrhage 08/2013 - 08/2006
2	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 11/2003 - 01/2003
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2022
1	Chickenpox 08/2022
1	Herpes Zoster 08/2022
1	Retinitis 08/2022
1	Breast Neoplasms (Breast Cancer) 10/2021
1	Optic Neuritis (Retrobulbar Neuritis) 03/2021
1	Multiple Sclerosis 03/2021
1	Vitiligo 01/2021

Drug/Important Bio-Agent (IBA)

23	Retinaldehyde (Retinal)IBA 09/2022 - 06/2005
19	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 06/2007
18	EnzymesIBA 01/2020 - 09/2004
15	ImmunosorbentsIBA 01/2020 - 09/2004
12	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022 - 04/2007
11	CytokinesIBA 04/2020 - 01/2012
11	Proteins (Proteins, Gene)FDA Link 02/2019 - 06/2007
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
9	ChemokinesIBA 01/2020 - 01/2003
8	HMGB1 Protein (HMG1)IBA 10/2019 - 01/2012
6	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2021 - 10/2010
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2010
5	Oxygen (Dioxygen)IBA 09/2022 - 01/2014
5	cobaltous chloride (cobalt(II)chloride)IBA 05/2021 - 12/2016
5	Matrix Metalloproteinases (MMPs)IBA 02/2018 - 08/2006
5	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2018 - 08/2006
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 12/2021 - 09/2016
3	Fluorescein (Funduscein)FDA LinkGeneric 03/2021 - 10/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2016
3	Interleukin-6 (Interleukin 6)IBA 06/2018 - 01/2013
3	cadherin 5IBA 03/2015 - 01/2012
3	lysophosphatidic acidIBA 12/2014 - 03/2012
3	Infliximab (Remicade)FDA Link 09/2014 - 06/2005
3	Chemokine ReceptorsIBA 06/2010 - 09/2006
2	Monoclonal AntibodiesIBA 04/2022 - 01/2021
2	Rituximab (Mabthera)FDA Link 04/2022 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2021 - 02/2015
2	Tissue Inhibitor of Metalloproteinase-3IBA 01/2021 - 02/2018
2	Streptozocin (Streptozotocin)FDA Link 01/2021 - 11/2014
2	Caspase 3 (Caspase-3)IBA 01/2021 - 02/2015
2	Interleukin-11 (Interleukin 11)IBA 05/2020 - 04/2020
2	Metalloproteases (Metalloproteinases)IBA 01/2020 - 02/2018
2	InterleukinsIBA 08/2019 - 08/2012
2	Interleukin-10 (Interleukin 10)IBA 08/2019 - 08/2012
2	Tuberculin (PPD)IBA 02/2019 - 12/2008
2	OsteoprotegerinIBA 01/2018 - 01/2017
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017 - 01/2013
2	heparanaseIBA 01/2016 - 12/2015
2	Syndecan-1 (Syndecan 1)IBA 12/2015 - 01/2014
2	Cadherins (E-Cadherin)IBA 03/2015 - 01/2012
2	EndoglinIBA 03/2015 - 01/2012
2	Receptor for Advanced Glycation End ProductsIBA 02/2015 - 01/2013
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 02/2015 - 10/2009
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2015 - 01/2013
2	OsteopontinIBA 01/2014 - 01/2012
2	ThrombospondinsIBA 08/2013 - 05/2013
2	acylglycerol kinaseIBA 06/2013 - 03/2012
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2013 - 01/2013
2	InterferonsIBA 08/2012 - 11/2003
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2012 - 06/2010
2	pigment epithelium-derived factorIBA 01/2012 - 06/2007
2	Connective Tissue Growth FactorIBA 01/2012 - 02/2007
2	Triamcinolone (Aristocort)FDA Link 04/2011 - 04/2010
2	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 04/2011 - 04/2010
2	Chemotactic FactorsIBA 09/2004 - 11/2003
1	Acyclovir (Aciclovir)FDA LinkGeneric 08/2022
1	Ganciclovir (Cytovene)FDA LinkGeneric 08/2022
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2022
1	FurinIBA 01/2022
1	matrigelIBA 10/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2021
1	NADPH Oxidases (NAD(P)H oxidase)IBA 05/2021

Therapy/Procedure

18	Therapeutics 08/2022 - 03/2005
6	Traction 06/2014 - 06/2005
4	Vitrectomy 01/2013 - 08/2006
2	Light Coagulation 04/2011 - 04/2010
2	Lasers (Laser) 04/2011 - 04/2010
1	Immunotherapy 08/2022
1	Cautery 10/2021
1	Immunomodulation 01/2021